Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2017

01-02-2017 | Clinical Practice: Clinical Images

Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu syndrome)

Author: Michael A. Santos, MD

Published in: Journal of General Internal Medicine | Issue 2/2017

Login to get access

Excerpt

A 79-year-old man with hereditary hemorrhagic telangiectasia (HHT, or Osler–Weber–Rendu syndrome) complicated by portal hypertension, hypoxemia from pulmonary shunting, congestive heart failure, and gastrointestinal bleeding was admitted for recurrent epistaxis. Examination revealed extensive telangiectasias on his back (Fig. 1) and classic blanching with pressure applied by a hand (Fig. 2).
Literature
1.
go back to reference Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995;333(14):918–924.CrossRefPubMed Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995;333(14):918–924.CrossRefPubMed
2.
go back to reference Sautter NB, Smith TL. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis. Otolaryngol Clin N Am. 2016;49(3):639–654.CrossRef Sautter NB, Smith TL. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis. Otolaryngol Clin N Am. 2016;49(3):639–654.CrossRef
4.
go back to reference Larson AM. Liver disease in hereditary hemorrhagic telangiectasia. J Clin Gastroenterol. 2003;36(2):149–158.CrossRefPubMed Larson AM. Liver disease in hereditary hemorrhagic telangiectasia. J Clin Gastroenterol. 2003;36(2):149–158.CrossRefPubMed
5.
go back to reference Daly JJ, Schiller AL. The liver in hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med. 1976;60(5):723–726.CrossRefPubMed Daly JJ, Schiller AL. The liver in hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med. 1976;60(5):723–726.CrossRefPubMed
6.
go back to reference Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J. 2003;79(927):18–24.CrossRefPubMedPubMedCentral Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J. 2003;79(927):18–24.CrossRefPubMedPubMedCentral
7.
go back to reference Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol. 2007;56(4):541–564.CrossRefPubMed Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol. 2007;56(4):541–564.CrossRefPubMed
Metadata
Title
Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu syndrome)
Author
Michael A. Santos, MD
Publication date
01-02-2017
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2017
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3870-4

Other articles of this Issue 2/2017

Journal of General Internal Medicine 2/2017 Go to the issue

Clinical Practice: Clinical Images

Approaching End-of-Life with Aplomb and Plombage

Clinical Practice: Clinical Images

Bullosis Diabeticorum

Editorial

Seeing Wisely

Letter to the Editor

Comparing VA to Non-VA Care

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.